解码乳腺癌休眠期的适应性生存机制
Francis M Barnieh1, Jamie Morton2, Olaitan Olanrewaju2
1Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK. f.mprahbarnieh1@bradford.ac.uk.
Oncogene
|August 27, 2025
概括
乳腺癌复发是由休眠的瘤细胞驱动的. 了解这些细胞是如何存活的,
科学领域:
- 癌症学
- 癌症生物学
背景情况:
- 乳腺癌 (BC) 复发是一个重要的临床问题,通常是由休眠的瘤细胞引起的.
- 调节BC休眠的机制尚不清楚,这阻碍了有效治疗的开发.
研究的目的:
- 审查诱导乳腺癌休眠的因素.
- 检查休眠BC细胞的生存机制.
- 确定预防BC复发的治疗策略.
主要方法:
- 对乳腺癌休眠期的临床前和临床研究的文献综述.
- 分析瘤缺氧,细胞外矩阵 (ECM) 重塑和治疗引起的压力等因素.
- 在休眠的BC细胞中评估细胞代谢,基因表达和免疫相互作用.
主要成果:
- 瘤缺氧,ECM重塑和治疗引起的压力是BC休眠的主要驱动因素.
- 休眠的BC细胞通过改变细胞代谢,基因表达和免疫规避来生存.
- 目前的临床前模型在将发现转化为临床应用方面存在局限性.
结论:
- 更深入地了解BC休眠机制对于开发向疗法至关重要.
- 需要消除休眠的BC细胞以防止复发.
- 解决临床前模型的缺陷将促进临床转换并改善患者的结果.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


